Impact of Fenebrutinib Treatment on MRI Outcomes and Cerebrospinal Fluid Penetrance in Multiple Sclerosis: Results from the Phase II FENopta Study (S31.004)

Amit Bar-Or,Michal Dufek,Hrvoje Budincevic,Jelena Drulovic,Mario Habek,Le H. Hua,Martin S. Weber,Piia Thomas,Julie Napieralski,David Clayton,Denison Kuruvilla, Qi, Yan Xu,Alexandra Goodyear,Jiwon Oh

Neurology（2024）

引用 0|浏览11

暂无评分

摘要

To evaluate the effects of fenebrutinib on MRI outcomes and the ability of fenebrutinib to enter cerebrospinal fluid (CSF) in the ongoing Phase II study FENopta (NCT05119569).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要